Novartis and Sun Pharma’s US subsidiary have settled litigation related to cancer drug Gleevec (imatinib mesylate) in the US, the companies announced today (May 15).
Johnson & Johnson’s pharmaceuticals subsidiary Janssen has sued Mylan to stop it launching a generic version of Concerta (methylphenidate hydrochloride).
Canadian pharmaceutical company Valeant announced yesterday (May 12) that it had settled all litigation related to its acne treatment Acanya (clindamycin phosphate and benzoyl peroxide) with Actavis.
The pharmaceutical industry, as well as food and alcoholic drink manufacturers, could be under pressure from the spread of plain and standardised packaging, delegates at INTA's annual meeting in Hong Kong were told today, May 12.
The US Court of Appeals for the Federal Circuit has ruled that mammals made using the cloning method that created Dolly the sheep are not patent eligible.
UK-based medical technologies manufacturer Hill-Rom has sued General Electric (GE), claiming that the company infringes three patents covering hygiene monitoring systems.
Acura Pharmaceuticals and Ranbaxy have agreed to settle their patent infringement litigation related to painkiller Aversion (oxycodone hydrochloride), once marketed by Pfizer under its registered trademark Oxecta.
The US Federal Trade Commission (FTC) has filed an amicus brief in an antitrust case that concerns a “no-authorised-generic” settlement between Teva and GlaxoSmithKline (GSK).
Allergan, along with Japan-based Senju and Kyorin have sued Indian pharma Aurobindo for infringing claims in the Japanese pharmaceutical companies’ reexamined US patent 6,333,045.
Bayer AG has agreed to buy New Jersey-based Merck’s consumer care business for $14.2 billion, the companies announced today (May 6).